Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Moclobemide (compound)
Most Correlated Studies
- Brain gene expression in R6/2 Huntington's disease mice treated with a combination drug therapy
- Drug target sets for approved compounds
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Most Relevant Literature
- Classification of LC columns based on the QSRR method and selectivity toward moclobemide and its met…
- Application of curve resolution algorithms in the study of drug photodegradation kinetics -- the exa…
- The predictive validity of atypical neurovegetative depressive symptoms identified by the first prin…
- Serotonin toxicity involving MDMA (ecstasy) and moclobemide.
- Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.
Most Relevant Clinical Trials
- Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Thera…
- Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation
- Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Or…
- Metoclopramide as Treatment of Clozapine-induced Hypersalivation
- Effects of ECT on Monoamine Oxidase A in Depression Investigated With PET
